Ann Arbor, MI, January 31, 2011 - In any situation, using adult-based tools on children is insufficient and potentially dangerous - particularly when it comes to determining appropriate drug doses. As a result, Thomson Reuters is pleased to announce the availability of Thomson Reuters Pediatrics, a single source solution to help clinicians improve quality, efficiency and care for pediatric patients.
Pediatric-specific referential drug dosing and nutritional information is necessary to safely medicate children. Backed by the trusted editorial content and clinical rigor that powers Micromedex® and Neofax, Thomson Reuters Pediatrics provides clinicians with the information and tools for an evidence-based approach to prescribing drugs to this vulnerable patient population.
"Medication safety for pediatric patients is a critical challenge for clinicians," said Thomson Hegelund, executive vice president at Thomson Reuters. "Determining the appropriate dosage for children isn't simply a matter of scaling doses down proportionally. We're pleased to offer a better way to address the medication and nutritional needs of the pediatric patient population."
Key features of Thomson Reuters Pediatrics include:
· patient-specific drug/TPN management system,
· pediatric referential drug monographs and enteral nutrition information,
· calculators for pediatric drug dosing based on patient-specific information, including indication, weight, and age (covering ages 29 days to 18 years), and
· parenteral nutrition order entry with pediatric-specific nutrient parameters and amino acids appropriate for the pediatric population (covering ages 29 days up to 11 years or 40 kilograms in weight).
"Most physicians note the lack of child-specific data as the primary gap in the tools currently available," Hegelund continued. "As a direct response to this customer request, we created dosing calculators that used pediatric-specific data instead of adult data modeled to fit pediatric patients."
For more information about Thomson Reuters Pediatrics, please visit www.micromedex.com/pediatrics.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.